Research location
New Lambton
Australia
Advertisement
Research activity in New Lambton
AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in New Lambton
19 linked trials · page 1 of 1A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)NCT06878261 · 2025-03-25 · 1 site observation
RECRUITING
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974 · 2024-09-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)NCT04783935 · 2021-03-10 · 1 site observation
COMPLETED
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaNCT03706079 · 2019-01-07 · 1 site observation
COMPLETED
PeriOperative ISchemic Evaluation-3 TrialNCT03505723 · 2018-06-27 · 1 site observation
COMPLETED
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaNCT03347279 · 2017-11-23 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsNCT02501629 · 2015-09-29 · 1 site observation
COMPLETED
A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract InfectionNCT02491684 · 2015-07-21 · 1 site observation
COMPLETED
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02155660 · 2014-06-25 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid ArthritisNCT01194414 · 2010-09-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01 · 1 site observation
COMPLETED
ACT-293987 in Pulmonary Arterial HypertensionNCT01112306 · 2010-07-07 · 1 site observation
COMPLETED
Selexipag (ACT-293987) in Pulmonary Arterial HypertensionNCT01106014 · 2009-12-01 · 1 site observation
COMPLETED
Atacicept in Multiple Sclerosis Extension Study, Phase IINCT00853762 · 2009-03-01 · 1 site observation
TERMINATED
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple SclerosisNCT00751881 · 2008-08-01 · 1 site observation
COMPLETED
A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)NCT00642902 · 2008-04-01 · 1 site observation
TERMINATED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)NCT00106535 · 2005-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisNCT00195663 · 2000-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.